MRSA Infections or Methicillin-resistant Staphylococcus aureus infections are difficult to treat due to resistance to the beta-lactam family of antibiotics. MRSA infections are commonly acquired in hospitals. Discover the latest research on MRSA Infections here.
ABC Transporters or ATP-Binding Cassette Transporters are responsible for pumping out antibiotics in the cell and can lead to multidrug resistance in bacteria. Discover the latest research on ABC Transporters & Multidrug Resistance here.
Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.
Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.
Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.
CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.
Drug inactivation or modification is one of the mechanisms through which resistance occurs. For instance, some penicillin-resistant bacteria produce beta-lactamases to enzymatically deactivate Penicillin G. Here is the latest research on drug inactivating enzymes and resistance.
Drug resistant infections are one of the biggest threats in our public health care system. Discover the latest research here.
Efflux-mediated drug resistance is one mechanism where bacteria can express proteins that pump out antibiotics, thereby rendering therapy ineffective. Discover the latest research on efflux-mediated drug resistance here.
Microbes in the gut communicate with the central nervous system (CNS) via at least three parallel and interacting channels including endocrine, nervous, and immune signaling. Here is the latest research on the brain-gut-microbiome axis.
Gut microbiota composition has been implicated in neuroinflammatory responses, as well as brain aging and brain-aging related diseases like amyloid neuropathies. Here is the latest research.